September 19, 2022
At biotech companies, things often evolve at light speed, and the natural tendency of a Chief Medical Officer (CMO) can be to try and manage every detail. But it’s a superhuman task, especially when powerful egos are in play.
This episode of The Emerging Biotech Leader features:
The team recaps Episode 1’s conversation with Dr. Suku Nagendran – President of R&D and Chief Medical Officer (CMO) at Jaguar Gene Therapy, and former CMO at Avexis, a gene therapy start-up that delivered a life-saving drug for infants suffering from Spinal Muscular Atrophy Type 1 and achieved unicorn status – about the challenges and rewards of being a CMO.
Anyone in a leadership position or who aspires to leadership will benefit from listening to the conversation.
A good CMO at a biotech company is like the conductor of a large orchestra; they must coordinate each section’s part in the symphony, as well as play to the audience. The conductor can’t play every instrument, and as CMO, you need the self-awareness that you can’t do it all, so surround yourself with people with expertise in areas you don’t have. Strong leadership requires confidence, emotional maturity, and faith in the team around you.
To make the most of your resources, be resourceful. You can outsource specialized expertise to fill stopgap needs rather than onboarding new hires. Especially early on in the development process.
But perhaps the best quote is from Dr. Nagendran: ”I’m a nobody who became a somebody because of all the people around me.”
Interested in being a guest on the show?
Watch the full episode on YouTube here: